ArticleBreast cancer research : BCR2024

Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer.

Caroline Rönnlund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.